Literature DB >> 14564157

Interstitial deletion of chromosome 2p16.2p21.

S R Sanders1, A J Dawson, A Vust, M Hryshko, M Tomiuk, D Riordan, C Prasad.   

Abstract

We report on a female who presents with an atrial septal defect (ASD), mild hypotelorism, a prominent nasal bridge, a long smooth philtrum, mild developmental delay and a de novo interstitial deletion of the short arm of chromosome 2p, del (2)(p16.2p21). This is the first report of a deletion in chromosome 2 involving those particular breakpoints. We propose that this may represent a new recognizable chromosomal phenotype.

Entities:  

Mesh:

Year:  2003        PMID: 14564157     DOI: 10.1097/01.mcd.0000065051.36236.e9

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  4 in total

Review 1.  Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.

Authors:  Erin E Salo-Mullen; Patricio B Lynn; Lu Wang; Michael Walsh; Anuradha Gopalan; Jinru Shia; Christina Tran; Fung Ying Man; Sean McBride; Mark Schattner; Liying Zhang; Martin R Weiser; Zsofia K Stadler
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.

Authors:  Jennifer L Roberts; Karine Hovanes; Majed Dasouki; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2013-11-02       Impact factor: 3.688

3.  Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.

Authors:  Jin Sook Lee; Hee Hwang; Soo Yeon Kim; Ki Joong Kim; Jin Sun Choi; Mi Jung Woo; Young Min Choi; Jong Kwan Jun; Byung Chan Lim; Jong Hee Chae
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

4.  Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.

Authors:  N van Engelen; F van Dijk; E Waanders; A Buijs; M A Vermeulen; J L C Loeffen; R P Kuiper; M C J Jongmans
Journal:  Fam Cancer       Date:  2021-04-03       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.